4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000030
Sr. VP & General Counsel acquired 2,519 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gardiner Nathaniel S. · Sr. VP & General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-06 | Exercise or conversion : show line 1 in the form | +1,724 | $34.70 | $59,823 | 25,702 | D |
| 2019-03-06 | Exercise or conversion : show line 2 in the form | +795 | $31.42 | $24,979 | 26,497 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-06 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −1,724 | $34.70 | 2024-05-09 | 1,724 | 70,976 | D |
| 2019-03-06 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −795 | $31.42 | 2025-11-20 | 795 | 24,705 | D |
Loading xslF345X03/edgar.xml…